| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 12/12/2007 | CN101085124A Traditional Chinese medicine composition for treating lupoid nephritis |
| 12/12/2007 | CN101085098A Capsule for treating nephrotic syndrome |
| 12/12/2007 | CN101085096A Method for extracting cordate houttuynia |
| 12/12/2007 | CN101085094A Anti-infectious compound andrographis preparation and its preparation technology |
| 12/12/2007 | CN101085088A Traditional Chinese medicine formula for treating prostatic hyperplasia |
| 12/12/2007 | CN101084940A Abelmoschus manihot health care soft capsule |
| 12/12/2007 | CN101084921A Active carbon intestinal bioadhesive preparation and preparation method thereof |
| 12/12/2007 | CN101084915A Method for preparing nitrobenzoic oxycelluloseester for urea, creatinine adsorbent |
| 12/12/2007 | CN101084891A Darifenacin or its pharmaceutical salt pharmaceutical preparation for oral |
| 12/12/2007 | CN101084878A Blood dialysate dry powder containing citrate |
| 12/12/2007 | CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/12/2007 | CN100354003C Sodium acetylide/ soybean separation protein commixed gel granule preparation method |
| 12/12/2007 | CN100353960C Yinhuang enema liquid for kindney deficiency and its preparing method |
| 12/12/2007 | CN100353935C Pharmaceutical formulation contg. tolterodine and its use |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307154 DNA encoding a novel RG1 polypeptide |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7306792 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2224164C Intrauterine chemical necrosing method and composition |
| 12/06/2007 | WO2007139921A2 N-oxides of kappa opioid receptor peptides |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139211A1 Process for production of optically active piperidine compound |
| 12/06/2007 | WO2007139036A1 Compound for controlling endoplasmic reticulum stress, and pharmaceutical composition comprising the compound as active ingredient |
| 12/06/2007 | WO2007139002A1 Method for producing nitrogen-containing fused ring compound |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138691A1 Polycystic kidney disease-related gene and use thereof |
| 12/06/2007 | WO2007137871A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 12/06/2007 | WO2007137833A1 Specifically adapted plant-derived redox catalyst and method for the production thereof |
| 12/06/2007 | US20070282126 Novel Crystal Of Triterpene Derivative |
| 12/06/2007 | US20070281954 Cyclohexyl-1,4-diamine compounds |
| 12/06/2007 | US20070281937 Use of various imidazole compounds such as 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof to treat angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or nervous system disorders |
| 12/06/2007 | US20070280958 homodimer-forming chemokines such as Chemokine (C-C motif) ligand 2 (CCL2) having a single amino acid substitution in the dimerization interface that alters the pattern of hydrogen bonds; for inflammatory, autoimmune, or infectious diseases |
| 12/06/2007 | US20070280886 Diagnostics and Therapeutics for Diseases Associated with Adrenomedullin Receptor (Amdr) |
| 12/06/2007 | DE102006025103A1 Spezifisch adaptierter pflanzlicher Redoxkatalysator, als Mittel zur Behandlung von Stoffwechselveränderungen und immunbiologischen Zellbelastungsschwächen sowie Verfahren zu dessen Herstellung Specifically adapted plant redox catalyst, as agents for the treatment of metabolic changes and immune cell biological stress weaknesses and method for its manufacture |
| 12/06/2007 | CA2653925A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653077A1 N-oxides of kappa opioid receptor peptides |
| 12/05/2007 | EP1862475A1 Polymer conjugates of neublastin and methods of using same |
| 12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases |
| 12/05/2007 | EP1862444A2 Ether compounds, compositions, and uses thereof |
| 12/05/2007 | EP1862172A1 Combination of amino acid solution and a gelatin for inhibiting renal uptake |
| 12/05/2007 | EP1862165A2 Prevention and treatment of androgen-deprivation induced hot flashes |
| 12/05/2007 | EP1861091A1 Compounds having lipid lowering properties |
| 12/05/2007 | EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 12/05/2007 | CN200984333Y Medical plaster for the adjuvant therapy of the acute nephritis |
| 12/05/2007 | CN101081865A Abstraction of pilose antler releasing somatomedin (DEER GHRF) and preparation method thereof |
| 12/05/2007 | CN101081276A Chinese medicinal materials for treating nephrolithiasis effectively |
| 12/05/2007 | CN101081260A Chinese medicinal materials preparations for treating bladder stone |
| 12/05/2007 | CN101081251A Polygonum multiflorum thunb processing method |
| 12/05/2007 | CN101081226A Novel use of medicine |
| 12/05/2007 | CN101081088A Beverage capable of preventing and curing males prostatitis |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
| 12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 12/05/2007 | CN100352474C Chinese medicinal preparation for treating urethra infection |
| 12/05/2007 | CN100352454C Chinese medicine preparation with invigorating kidney function |
| 12/05/2007 | CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 12/05/2007 | CN100352431C Pharmaceutical salts |
| 12/04/2007 | US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability |
| 12/04/2007 | US7304090 Using fluorescein; polycystic kidney disease, diarrhea, antiarrhythmia agents, antitumor agents, contraceptice |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303755 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine |
| 12/04/2007 | CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells |
| 12/04/2007 | CA2255891C Compositions and methods for treating or preventing diseases of body passageways |
| 12/04/2007 | CA2212205C Use of xanthine derivatives for the modulation of apoptosis |
| 11/29/2007 | WO2007136125A1 Compound having heterocyclic ring and use thereof |
| 11/29/2007 | WO2007135547A2 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
| 11/29/2007 | WO2007112204A3 Ingestible compositions containing extracts |
| 11/29/2007 | WO2007112073A3 Methods for modulating bladder function |
| 11/29/2007 | WO2007076159A3 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
| 11/29/2007 | WO2007051463A3 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 11/29/2007 | US20070276046 Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents |
| 11/29/2007 | US20070276039 Pharmaceutical uses for alpha2delta ligands |
| 11/29/2007 | US20070275950 2-Phenylpyridine Derivative |
| 11/29/2007 | US20070275882 Nature-Identical Erythropoietin |
| 11/29/2007 | US20070275437 Antibodies to G protein-coupled receptor |
| 11/29/2007 | US20070275110 Botulinum Toxin Treatment Of Spastic Bladder |
| 11/29/2007 | US20070275086 Use of Increased Molecular-Weight Hirudin as an Anticoagulant in Extracorporeal Kidney Replace Therapy |
| 11/29/2007 | US20070274913 Preventives/Remedies for Stress Urinary Incontinence and Method of Screening the Same |
| 11/29/2007 | US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 11/29/2007 | CA2652783A1 Selective estrogen receptor modulators or aromatase inhibitors for treating chronic nonbacterial prostatitis |
| 11/28/2007 | EP1860106A1 Tricyclic thrombin receptor antagonists |
| 11/28/2007 | EP1858874A1 (s)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof |